IP Library Granted Patent US 8,486,426
Granted Patent B2
US 8,486,426 · App. 10/630,627 · Granted Jul 16, 2013

Methods and compositions for treatment of dermal conditions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,486,426
App. No.
10/630,627
Granted
Jul 16, 2013
Kind
B2
Abstract

The present invention comprises methods and compositions for the treatment of pathological conditions of the dermis and dermal structures of animals and humans. In particular, the present invention comprises the use of topical delivery vehicles, including hydrogels, which incorporate active agents such as organic acids, for the treatment of dermal conditions.

Claims (14)

1. A method of treating a ungual condition comprising,

a) applying to an ungual structure a composition comprising: a hydrophilic polymer matrix, wherein the hydrophilic polymer matrix includes a cross-linked polyacrylamide; at least one active agent, wherein the at least one active agent comprises a citric acid present at a concentration of from about 0.1% w/w to about 16% w/w; at least one humectant, wherein the humectant is present at a concentration of from about 15% to about 25w/w, further wherein in humectant includes glycerol; a moisture management system, wherein the moisture management system includes a non-gellable polysaccharide, wherein the non-gellable polysaccharide comprises guar gum, lucerne, fenugreek, honey locust bean gum, white clover bean gum, or carob locust bean gum; a moisture content ranging from 0.1% to 50% to create a diffusion gradient from the composition to the ungual structure, wherein the hydrophilic polymer matrix directly contacts the ungual structure, wherein moisture and the at least one active agent are transferred by the diffusion gradient from the hydrophilic polymer matrix composition to the ungual structure; and an open pattern adhesive, wherein the open pattern adhesive comprises a polvsiloxane, a polyisobutylene, a polyacrylate, an acrylic acid-acrylate copolymer, a polyisobutene, a polybutadiene, a polystyrene-isoprene copolymer, a polystyrene-butadiene copolymer, a neoprene, a polyacrylic acid, a polymethacrylic acid, or a blend of a hydrophilic cellulose derivative with a polyethylene glycol; and

b) maintaining the composition at the ungual structure site for a sufficient amount of time so that an effective amount of the active agent is delivered.

2. The method of claim 1 , wherein the citric acid is present at in a concentration between 4% w/w and 16% w/w.

3. An antifungal nail treatment composition comprising,

a) a solid matrix sheet comprising a hydrophilic polymer matrix, wherein the hydrophilic polymer matrix includes a cross-linked polyacrylamide;

b) at least one active antifungal agent, wherein the at least one active agent comprises a citric acid present at a concentration of from about 0.1% w/w to about 16% w/w;

c) at least one humectant, wherein the humectant is present at a concentration of from about 15% w/w to about 25% w/w, further wherein the humectant includes glycerol;

d) a moisture management system, wherein the moisture management system includes a non-gellable polysaccharide, wherein the non-gellable polysaccharide comprises guar gum, lucerne, fenugreek, honey locust bean gum, white clover bean gum, or carob locust bean gum;

e) a moisture content ranging from 0.1% to 50% to create a diffusion gradient from the composition to an ungual structure, wherein moisture and the at least one active agent are transferred from the hydrophilic polymer matrix composition to the ungual structure when the composition contacts the ungual structure; and

f) an open pattern adhesive, wherein the open pattern adhesive comprises a polysiloxane, a polyisobutylene, a polyacrylate, an acrylic acid-acrylate copolymer, a polyisobutene, a polybutadiene, a polystyrene-isoprene copolymer, a polystyrene-butadiene copolymer, a neoprene, a polyacrylic acid, a polymethacrylic acid, or a blend of a hydrophilic cellulose derivative with a polyethylene glycol.

4. The composition of claim 3 , wherein the citric acid is present at in a concentration of from about 8% to about 16% w/w.

5. The composition of claim 3 , wherein the composition inhibits the growth of fungi in a zone of inhibition of up to about 12millimeters.

6. The composition of claim 5 , wherein the fungi comprises trichophyton, epidermophyton, microsporum, or combinations thereof.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Jun 30, 2022
From: CITIBANK, N.A.
To: AVENT, INC.; AVANOS MEDICAL SALES, LLC
Reel/Frame 060557/0062 →
SECURITY INTEREST Recorded Jun 24, 2022
From: AVENT, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 060441/0445 →
INTELLECTUAL PROPERTY SECURITY INTEREST ASSIGNMENT AGREEMENT Recorded Jan 23, 2019
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: CITIBANK, N.A.
Reel/Frame 048173/0137 →
SECURITY INTEREST Recorded Apr 6, 2015
From: AVENT, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 035375/0867 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2015
From: KIMBERLY-CLARK WORLDWIDE, INC.
To: AVENT, INC.
Reel/Frame 034753/0001 →
MERGER Recorded Aug 23, 2011
From: ACRYMED INCORPORATED
To: I-FLOW CORPORATION
Reel/Frame 026793/0556 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2011
From: I-FLOW CORPORATION
To: KIMBERLY-CLARK WORLDWIDE, INC.
Reel/Frame 026793/0802 →
NUNC PRO TUNC ASSIGNMENT Recorded Feb 15, 2008
From: GIBBINS, BRUCE L.
To: ACRYMED, INC.
Reel/Frame 020517/0151 →